# Lumere

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lumere

- Industry: Software
- Headquarters: Chicago, US
- Website: www.lumere.com
- Total disclosed funding: $5.1M
- Latest round: Series A (Mar 20, 2014)
- Investors on record: 8

## About

Lumere, Inc. is a healthcare technology company that delivers data-driven insights for optimizing supply chain management and improving patient outcomes by leveraging evidence-based analytics.Founded in 2012, Lumere, Inc. operates in Chicago, US, focusing on providing analytics and management solutions specifically for the healthcare sector. The company was acquired by Global Healthcare Exchange, LLC on January 13, 2020. Lumere was previously supported by several investors including Bessemer Venture Partners and HCA Holdings Inc. The latest funding round was a Growth round, raising USD 4.98 mn led by Heritage Group, bringing the total amount raised to USD 4.98 mn.Lumere specializes in data management solutions tailored for the healthcare industry. Its core offerings include a Value Analysis platform that utilizes evidence-based insights to enhance supply selection and utilization. This platform aims to improve operational efficiency and reduce costs in healthcare delivery, serving clients such as the Defense Health Agency and various healthcare providers across North America and Europe.Lumere operates on a subscription-based model for its software solutions, ensuring clients have ongoing access to its Value Analysis platform and associated services. Revenue is generated through contractual agreements with healthcare providers who utilize Lumere's tools to enhance procurement and supply chain operations.The acquisition by Global Healthcare Exchange, LLC in January 2020 positions Lumere for strategic growth. The company plans to expand its product offerings and enhance its Value Analysis platform. Targeted expansion into new geographic markets, particularly across North America and Europe, is expected to take place over the next few years. Recent funding will likely be utilized to bolster product development and facilitate market entry.

## Funding rounds

- Series A, Mar 20, 2014, $4M — Clayton Associates, Jump Capital, Wintrust Financial Corporation
- Seed, Aug 3, 2012, $1.1M — Bessemer Venture Partners, F-Prime Capital, Zimmerman Ventures, Silicon Badia, Blueprint Health

## Investors

- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Seed
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Seed
- Zimmerman Ventures (https://capitalatlas.ai/funds/zimmerman-ventures) — Seed
- Silicon Badia (https://capitalatlas.ai/funds/silicon-badia) — Seed
- Blueprint Health — Seed
- Clayton Associates (https://capitalatlas.ai/funds/clayton-associates) — Series A
- Jump Capital (https://capitalatlas.ai/funds/jump-capital) — Series A
- Wintrust Financial Corporation — Series A